Treatment of sporadic inclusion body myositis with bimagrumab

OBJECTIVE: To study activin signaling and its blockade in sporadic inclusion body myositis (sIBM) through translational studies and a randomized controlled trial. METHODS: We measured transforming growth factor β signaling by SMAD2/3 phosphorylation in muscle biopsies of 50 patients with neuromuscul...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neurology
Glavni autori: Amato, Anthony A., Sivakumar, Kumaraswamy, Goyal, Namita, David, William S., Salajegheh, Mohammad, Praestgaard, Jens, Lach-Trifilieff, Estelle, Trendelenburg, Anne-Ulrike, Laurent, Didier, Glass, David J., Roubenoff, Ronenn, Tseng, Brian S., Greenberg, Steven A.
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277670/
https://ncbi.nlm.nih.gov/pubmed/25381300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001070
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items